產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-BSCL2抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-BSCL2抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-BSCL2
Cat. Number:
Anti-BSCL2抗體KL-6311R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Defects in BSCL2 are theAnti-BSCL2抗體 cause of congenital generalized lipodystrophy type 2 (CGL2) . Congenital generalized lipodystrophy is an autosomal recessive disorder characterized by a near absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes.
Defects in BSCL2 are the cause of spastic paraplegia type 17 (SPG17) ; also known as Silver spastic paraplegia syndrome.Anti-BSCL2抗體 Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. SPG17 is characterized by prominent amyotrophy of the hand muscles, the presence of mild to severe pyramidal tract signs, and spastic paraplegia.
SPG17 is a motor neuron disease overlapping with distal spinal muscular atrophy type 5. Defects in BSCL2 are a cause of distal hereditary motor neuropathy type 5 (HMN5); also known aS distal hereditary motor neuropathy type V (DSMAV). HMN5 is an autosomal dominant disorder characterized by degenerationAnti-BSCL2抗體 of motor nerve fibers, predominantly in limb distal regions.
Defects in BSCL2 are the cause of spastic paraplegia type 17 (SPG17) ; also known as Silver spastic paraplegia syndrome.Anti-BSCL2抗體 Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. SPG17 is characterized by prominent amyotrophy of the hand muscles, the presence of mild to severe pyramidal tract signs, and spastic paraplegia.
SPG17 is a motor neuron disease overlapping with distal spinal muscular atrophy type 5. Defects in BSCL2 are a cause of distal hereditary motor neuropathy type 5 (HMN5); also known aS distal hereditary motor neuropathy type V (DSMAV). HMN5 is an autosomal dominant disorder characterized by degenerationAnti-BSCL2抗體 of motor nerve fibers, predominantly in limb distal regions.
Also known as:
Bernardinelli Seip congenital lipodystrophy 2; Bernardinelli Seip congenital lipodystrophy type 2 protein; Bernardinelli-Seip congenital lipodystrophy type 2 protein; BSCL 2; BSCL2; BSCL2_HUMAN; GNG3LG; HMN 5; HMN5; MGC4694; Seipin; Spastic paraplegia 17 (autosomal dominant); Spastic paraplegia 17 (Silver syndrome); Spastic paraplegia 17; Spastic paraplegia with amyotrophy of hands andAnti-BSCL2抗體 feet (Silver syndrome); Spastic paraplegia with amyotrophy of hands and feet; SPG 17; SPG17.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human BSCL2/SPG17.
●
Predicted Molecular Weight: 44kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl347Hu01 垂體腺苷酸環(huán)化酶激活肽(ADCYAP1)多克隆抗體 Polyclonal Antibody to Adenylate Cyclase Activating Polypeptide 1, Pituitary (ADCYAP1)
kl347Mu01 垂體腺苷酸環(huán)化酶激活肽(ADCYAP1)多克隆抗體 Polyclonal Antibody to Adenylate Cyclase Activating Polypeptide 1, Pituitary (ADCYAP1)
kl347Ra01 垂體腺苷酸環(huán)化酶激活肽(ADCYAP1)多克隆抗體 Polyclonal Antibody to Adenylate Cyclase Activating Polypeptide 1, Pituitary (ADCYAP1)
kl348Hu01 腺苷酸環(huán)化酶1(ADCY1)多克隆抗體 Polyclonal Antibody to Adenylate Cyclase 1, Brain (ADCY1)
kl350Hu01 脂肪分化相關(guān)蛋白(ADRP)多克隆抗體 Polyclonal Antibody to Adipose Differentiation Related Protein (ADRP)
kl354Hu01 芳香烴受體(AhR)多克隆抗體 Polyclonal Antibody to Aryl Hydrocarbon Receptor (AhR)
kl354Mu01 芳香烴受體(AhR)多克隆抗體 Polyclonal Antibody to Aryl Hydrocarbon Receptor (AhR)
kl354Ra01 芳香烴受體(AhR)多克隆抗體 Polyclonal Antibody to Aryl Hydrocarbon Receptor (AhR)
kl355Hu01 花生四烯酸-5-脂加氧酶(ALOX5)多克隆抗體 Polyclonal Antibody to Arachidonate-5-Lipoxygenase (ALOX5)
kl355Mu01 花生四烯酸-5-脂加氧酶(ALOX5)多克隆抗體 Polyclonal Antibody to Arachidonate-5-Lipoxygenase (ALOX5)
kl355Ra01 花生四烯酸-5-脂加氧酶(ALOX5)多克隆抗體 Polyclonal Antibody to Arachidonate-5-Lipoxygenase (ALOX5)
kl357Hu01 細(xì)胞外信號(hào)調(diào)節(jié)激酶1(ERK1)多克隆抗體 Polyclonal Antibody to Extracellular Signal Regulated Kinase 1 (ERK1)
kl358Hu01 凋亡信號(hào)調(diào)節(jié)激酶I(ASK1)多克隆抗體 Polyclonal Antibody to Apoptosis Signal Regulating Kinase 1 (ASK1)
kl360Hu01 酸性神經(jīng)鞘磷脂酶(ASM)多克隆抗體 Polyclonal Antibody to Acid Sphingomyelinase (ASM)
kl361Hu01 ****擴(kuò)張性共濟(jì)失調(diào)突變因子(ATM)多克隆抗體 Polyclonal Antibody to Ataxia Telangiectasia Mutated (ATM)
kl364Hu01 乳腺癌易感蛋白2(BRCA2)多克隆抗體 Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
kl364Mu01 乳腺癌易感蛋白2(BRCA2)多克隆抗體 Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
kl365Hu01 葡萄糖激酶調(diào)節(jié)蛋白(GKRP)多克隆抗體 Polyclonal Antibody to Glucokinase Regulatory Protein (GKRP)
kl366Hu01 血管內(nèi)皮鈣黏蛋白(CDH5)多克隆抗體 Polyclonal Antibody to Cadherin 5 (CDH5)
kl366Mu01 血管內(nèi)皮鈣黏蛋白(CDH5)多克隆抗體 Polyclonal Antibody to Cadherin 5 (CDH5)
